Français Give Now Media Blog
 

Prostate Cancer Canada is the leading national charity addressing prostate cancer needs across the country. Join us to save and improve more lives.
Expert Angle

Interested in learning more about prostate cancer care from various healthcare professionals and researchers? Register for PCC’s Expert Angle webinars now and start watching right away!

Tune In

To access all of our past webinars, visit our Past Presentations page.

 
     


Basics of Prostate Cancer

February 21, 2019
Understanding Your Pathology Report
Length
13 mins
Overview
Dr. Dominique Trudel highlights how pathologists interpret biopsy test results. This includes understanding a tumour grade, volume and stage. A pathologist will use this information to determine whether the cancer is likely to spread or be aggressive, which will influence treatment strategies.

For additional information on diagnosing prostate cancer, click here.
 
Speaker
Dr. Dominique Trudel is a genitourinary and molecular pathologist at the CHUM (Montréal). She heads a research laboratory who are working to improve how pathologists identify patients with aggressive prostate cancer. Dr. Trudel has received funding from Prostate Cancer Canada, the Institut du cancer de Montréal, Fonds de recherche du Québec – Santé (FRQS), Cancer Research Society, MEDTEQ, Institute for data valorization (IVADO) and the Canadian Institutes of Health Research (CIHR).
Join now
http://bit.ly/2GTh3Rk
Dr. Dominique Trudel

Testing and Diagnosis

September 03, 2019
Prostate Cancer Screening and Early Diagnosis in Canadian Men
Length
15 mins
Overview
When detected early, the survival rate for prostate cancer is much higher than when it’s diagnosed at later stages. In this webinar, Dr. Ross Mason discusses the PSA test which is used to help detect prostate cancer. Dr. Mason explains what the PSA test is, its advantages and disadvantages, and the Canadian Urological Association’s current recommendations for screening. You will also find out what the next steps are if a PSA test comes back high, and what questions you should ask your doctor about the test results.

Find out more about the PSA test.
Speaker
Dr. Ross Mason completed a Bachelor of Science in Chemistry before attending Dalhousie University for Medical School and a residency in Urology. He completed a Society of Urologic Oncology accredited fellowship in Urologic Oncology at the Mayo Clinic in Rochester, Minnesota where he also completed a Master's Degree in Clinical and Translational Science. His clinical and research interests include all aspects of urologic cancer with a particular focus on the kidneys, prostate, and bladder.
Join now
http://bit.ly/326muDW

Health and Wellness


April 02, 2019
Caregiver: Your New Reality
Length
11 mins
Overview
Roberta Casabon shares her perspective on being a caregiver and her experience with prostate cancer. From receiving her late husband’s diagnosis to making plans and being prepared, Roberta shares practical tips and wisdom to support caregivers experiencing similar situations.

For additional information and support for caregivers and partners, click here.
 
Speaker
Roberta Casabon is a widowed survivor of prostate cancer who donates her time to Prostate Cancer Canada frequently by adding her support and voice to public awareness campaigns. She has been a member of several pan-Canadian and global committees as part of the TrueNTH initiative and is an advisor for the Peer Navigation Program. Roberta was a member of the inaugural group of patients/caregivers who were trained for the Canadian Cancer Research Alliance’s Patient Involvement in Cancer Research Program (PIP). In her role as an advocate for the caregiver/partner, she gives a voice to the supportive caregiver community. Roberta seeks to expand connections between patients/caregivers, other widowed survivors and the research community.
Join now
http://bit.ly/2V329MH

Treatment and Side Effects


November 04, 2019
Toxicity of Treatments for Metastatic Castration-Resistant Prostate Cancer
Length
24 mins
Overview
To make the best treatment decisions for older men, both doctors and patients need to understand the potential side effects. Dr. Alibhai shares recent results comparing the severity of side effects of common treatments for men with an advanced form of prostate cancer called metastatic castration-resistant prostate cancer. He also explores if overall health before treatment impacts the severity of side effects. 
Speaker
Dr. Shabbir Alibhai is a Professor in the Department of Medicine, the Institute of Health Policy, Management, and Evaluation, and the Institute of Medical Sciences at the University of Toronto.  He is a staff physician in the Division of General Internal Medicine and Geriatrics at the University Health Network and Mount Sinai Hospital, a senior scientist at the Toronto General Research Institute and the Toronto Rehabilitation Institute, and a prior Research Scientist of the Canadian Cancer Society.  His research interests are in geriatric oncology, particularly in the impact of disease and treatment on quality of life and function of patients with prostate cancer, the value of geriatric assessment in older adults with cancer, and randomized trials of exercise to improve outcomes in older adults with cancer.  Since 2015, he is also the medical lead for the geriatric oncology program at the Princess Margaret Cancer Centre, Canada’s largest academic cancer centre.
Join now
http://bit.ly/31ZBVxd
​Dr. Shabbir Alibhai
October 09, 2019
Exercise for Men on Hormone Therapy
Length
16 mins
Overview
Hormone therapy is used to slow cancer growth by blocking male sex hormones. In this webinar, Dr. Alibhai describes how exercise can help reduce the side effects of hormone therapy including fatigue, muscle loss and reduced bone density. Dr. Alibhai will also explain what types of exercise are the most effective and discuss some of the most current research in the field.

Find out more about hormone therapy here.
Speaker
Dr. Shabbir Alibhai is a Professor in the Department of Medicine, the Institute of Health Policy, Management, and Evaluation, and the Institute of Medical Sciences at the University of Toronto.  He is a staff physician in the Division of General Internal Medicine and Geriatrics at the University Health Network and Mount Sinai Hospital, a senior scientist at the Toronto General Research Institute and the Toronto Rehabilitation Institute, and a prior Research Scientist of the Canadian Cancer Society.  His research interests are in geriatric oncology, particularly in the impact of disease and treatment on quality of life and function of patients with prostate cancer, the value of geriatric assessment in older adults with cancer, and randomized trials of exercise to improve outcomes in older adults with cancer.  Since 2015, he is also the medical lead for the geriatric oncology program at the Princess Margaret Cancer Centre, Canada’s largest academic cancer centre.
Join now
http://bit.ly/2Mv7oBX
June 20, 2019
I am interested in participating in a clinical trial – what’s next?
Length
13 mins
Overview
Dr. Paul Toren discusses the clinical trial process from beginning to end. This includes how eligibility is decided, what it means to provide consent to participate, the benefits and risks of participation, and a discussion of the most common types of clinical trials. Dr. Toren also explains what types of healthcare professionals are involved in clinical trials and what their roles are in your care. This webinar is presented in collaboration with Q-CROC. For additional information on clinical trials, click here.
Speaker
Dr. Toren completed medical school at Queen's University in Kingston, Ontario and his urology residency and a one-year clinical uro-oncology fellowship at the University of Toronto.  Subsequently, he completed a two-year research fellowship at the Vancouver Prostate Centre at the University of British Columbia under the mentorship of Drs. Martin Gleave and Amina Zoubeidi. His research, which led to a PhD from the Experimental Medicine Program at the University of British Columbia, focused on molecular mechanisms of enzalutamide resistant prostate cancer. He currently holds a clinician-scientist position in the Department of Surgery at Laval University where he pursues his interests in translational prostate cancer research. His research focuses on understanding factors within the prostate cancer microenvironment, which may act as biomarkers or therapeutic targets to delay the development of treatment resistance.
Join now
http://bit.ly/2KpkhPk
May 15, 2019
The Basics about Clinical Trials
Length
16 mins
Overview
Dr. Dawn Richards explains the role of CTO and practical tips on how to find a clinical trial in Canada. Other topics include the types of treatments and interventions studied most often, why clinical trials are important, how to find out if a clinical trial is reputable, how clinical trials are designed and information about CTO’s new tool to find trials across Canada.

For additional information on clinical trials, click here.
Speaker
Dawn Richards, PhD, is the founder of Five02 Labs Inc., and Director of Patient and Public Engagement at Clinical Trials Ontario. With a PhD (Analytical Chemistry) from the University of Alberta and experience in a variety of roles during the past 15 years, it is her diagnosis with rheumatoid arthritis ten years ago that instigated a journey to combine her passion for science with making the most of her diagnosis. In her role at CTO, Dawn is charged with executing on CTO’s strategic pillar of patient and public engagement. Dawn is also Vice President of the Canadian Arthritis Patient Alliance, a Research Ambassador for the Institute of Musculoskeletal Health and Arthritis (of the Canadian Institutes for Health Research), and a member of The BMJ’s Patient Panel Reviewers, and was the first Patient Advisor of the Canadian Medical Association’s Wait Time Alliance. 
Join now
https://bit.ly/2EcT7GG
Dawn Richards
January 17, 2019
Prostate Cancer Treatment Side Effects for Men-Who-Have-Sex-with-Men (MSM)
Length
15 mins
Overview
This webinar describes the side effects of prostate cancer treatment specifically for MSM. Dr. Lee reviews recent research on prostate cancer’s impact on the quality of life and sexuality of men within this community, including testimonials from patients. He also shares helpful information about the emergence of prostate cancer LGBTQ-focused support groups and future directions in healthcare and research to better serve the MSM population.

For additional resources on prostate cancer for gay and bisexual men, click here.        
 
Speaker
Dr. Tsz Kin Bernard Lee is a Radiation Oncologist with relevant clinical knowledge of prostate cancer treatment. He is also openly gay, with knowledge of MSM’s sexual practices and concerns. Dr. Lee received a Master degree in Medical Genetics at the University of British Columbia, a medical degree from the University of Alberta, his Radiation Oncology residency at the University of Ottawa and completed a Genitourinary Fellowship at BC Cancer. His research has been supported by the Canadian Institutes of Health Research, Canadian Association of Radiation Oncology and Prostate Cancer Canada.
Join now
https://bit.ly/2AOhAQC
Dr. Bernard Lee
Once you register, you should gain access to the webinar right away through your internet browser. If you encounter any issue, please email: expertangle@prostatecancer.ca.
 

Stay tuned for information on upcoming webinars. Click here to view collection of webinar content.

  

For more information and support:

Tune In

Donate Now!






Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.
More

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground
More

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive
Please note we cannot provide medical advice or endorse specific services, products, treatments or medical centres.